IVF vs CTKB

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 12, 2026

IVF

32.2
AI Score
VS
CTKB Wins

CTKB

47.7
AI Score

Investment Advisor Scores

IVF

32score
Recommendation
SELL

CTKB

48score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric IVF CTKB Winner
Revenue 1.64M 145.50M CTKB
Net Income -17.40M -37.12M IVF
Net Margin -1063.0% -25.5% CTKB
Operating Income -1.20M -38.29M IVF
ROE 64.0% -11.6% IVF
ROA -54.8% -8.3% CTKB
Total Assets 31.74M 446.14M CTKB
Cash 840,407 66.81M CTKB
Current Ratio 0.08 4.46 CTKB
Free Cash Flow -3.56M -11.71M IVF

Relative Price Performance (Last 90 Days)

IVF 1M: +320.4% · 3M: +177.3% CTKB 1M: +7.7% · 3M: +17.8%

Current Technical Phase

IVF

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (8.3% over 20 days), RSI 88

RSI (14): 87.9 · Price: $2.69

CTKB

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (8.9% over 20 days), RSI 52

RSI (14): 52.0 · Price: $5.76

Fundamentals Snapshot

Metric IVF CTKB
Market Cap — —
Forward P/E -0.1 -20.2
Trailing P/E 0.0 —
Revenue (TTM) — —
Revenue Growth 0.2% 0.0%
Gross Margin 0.4% 0.5%
Operating Margin -0.6% -0.2%
EPS 511.80 -0.63
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, CTKB is currently the stronger investment candidate, winning 6 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.